Status:
COMPLETED
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN
Lead Sponsor:
AstraZeneca
Conditions:
NSCLC
Eligibility:
All Genders
18+ years
Brief Summary
To provide accurate and reliable information regarding NSCLC clinical management across European countries in order to detect unmet medical needs of this disease in terms of: patient and hospital char...
Eligibility Criteria
Inclusion
- Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between January 1st, 2009 and March 31st, 2009.
- For PRO sub-sample: ability to read and write since they will be asked to participate in the PRO part of the study. Selection will not be based on the disease stage of each patient, in order to avoid a selection bias.
Exclusion
- According to the study design there will not be any exclusion criteria in order to provide a high external validity and to obtain the most accurate real daily practice information.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
3513 Patients enrolled
Trial Details
Trial ID
NCT00831909
Start Date
January 1 2009
End Date
July 1 2010
Last Update
August 10 2010
Active Locations (162)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Antwerp, Belgium
2
Research Site
Brussels, Belgium
3
Research Site
Genk, Belgium
4
Research Site
Herstal, Belgium